Workflow
睡眠健康
icon
Search documents
原来很多人都用错枕头!医生建议→
Xin Lang Cai Jing· 2026-02-28 00:40
你一般在睡觉时使用几个枕头?你有没有发现在日常入住酒店时,许多酒店都会为客人提供两个枕头。难道一个人在睡觉时真的需要两个枕头吗? 真相是,的确如此。很多医生都建议,睡觉时用两个枕头对睡眠健康会更好。 01 为什么睡觉需要两个枕头? 我们的腰椎是有曲度的,因此一个人睡觉需要两个枕头,一个垫在脖子下,另一个垫在腿下面。 第一个枕头:枕脖子和头 02 枕头并不只是只用来枕头的。睡觉时只把后脑勺垫在枕头上,会让肩膀、颈椎与枕头之间出现悬空状态,不利于颈部肌肉的休息和放松,导致睡醒之后可 能会感觉脖子疼痛。 解放军总医院第四医学中心骨科医生宋科冉解释,人类的颈椎正常存在一个10~15度的生理前凸,这个前凸会随着低头消失,仰头会增加。在现代生活节 奏下,低头族越来越多,在低头状态下,前凸是消失的,白天颈椎后部结构是很疲劳的,经常处于一种过于牵拉的状态。 因此,晚上在睡觉的时候,应该让枕头为颈部和头部,提供一个良好的支撑,维持住它们相对的位置关系。 四川大学华西医院康复医学中心建议: 第二个枕头:枕在腿部 广州医科大学附属第三医院中医科主任医师胥海斌介绍,如果想更好地保护脊椎或者有腰部或腿部不适,可以使用另一个枕头。 侧卧 ...
王腾回应换iPhone17,称因适配睡眠监测设备
3 6 Ke· 2026-02-20 15:35
Core Viewpoint - Wang Teng, the founder of Today Sleep Technology, has publicly switched to using an iPhone 17 for better compatibility with sleep monitoring devices, marking his first use of a non-Xiaomi phone since leaving the company in September 2025 [1] Group 1: Company Transition - Wang Teng previously served as the General Manager of Xiaomi's China Marketing Department and General Manager of the REDMI brand before founding Today Sleep Technology [1] - The company, Today Sleep Technology, was established in January 2026 and has completed seed round financing of several million yuan [1] Group 2: Product and Market Insights - Wang Teng highlighted that sleep is a complex system requiring multifaceted improvements, sharing his sleep data from the past six months [1] - The switch to iPhone 17 was specifically due to better adaptation with sleep monitoring devices such as Whoop, Oura, and Eight Sleep [1]
对话冯琏:64岁,我的第六次创业
吴晓波频道· 2026-02-13 01:37
Core Viewpoint - The article discusses the evolution of the sleep health industry in China, highlighting the journey of Feng Lian, who transitioned from a traditional career to pioneering a new market focused on sleep products, emphasizing the importance of sleep for overall well-being and quality of life [3][4]. Group 1: Industry Evolution - The concept of sleep health has transformed from a personal issue to a public concern, with the World Sleep Day 2026 theme emphasizing its significance for a better life [3]. - Feng Lian's journey reflects the industry's growth from a non-existent market to a recognized sector, focusing on creating a sleep ecosystem rather than just selling mattresses [3][4]. Group 2: Product Innovation - The company specializes in developing sleep products using a proprietary "gem fiber" material, which enhances sleep quality through its unique properties [8][9]. - The focus is on creating a comprehensive sleep environment with products like thin pads, bedding, and pillows, rather than competing directly with established mattress brands [8][9]. Group 3: Market Strategy - The company targets a broad demographic, initially focusing on the elderly but expanding to include middle-aged and young consumers, addressing the widespread sleep issues across different age groups [19][20]. - The strategy includes launching brands tailored for different demographics, such as "Meimian" for young adults and "Magic Exam" for children, emphasizing the importance of sleep for growth and development [21]. Group 4: Long-term Vision - The company aims to contribute to societal issues related to sleep disorders and aging, with plans for future collaborations in research and technology [26]. - Feng Lian emphasizes the importance of maintaining a long-term perspective in business, focusing on creating genuine value rather than chasing short-term profits [27][30].
熬夜不好,睡太早也不行!“最佳入睡时间”其实是......
Xin Lang Cai Jing· 2026-01-31 16:26
在这个快节奏的时代,睡眠仿佛成了一场"战争"。每一天,我们都在两种声音中拉扯:一边是长辈语重 心长的教诲:"早睡早起身体好,晚睡就是在熬心血!"一边是无奈的现实:"晚上不想睡,早上起不 来。周末不睡到日上三竿,怎么对得起这一周受的苦?" 所以早睡早起真的是健康的唯一标准吗?晚睡晚起(如果睡够了时间)真的会伤身吗?这两种到底哪个 好? 早睡早起VS晚睡晚起 哪个好? 2026年1月,《美国心脏协会杂志》刊发的一项研究,追踪了约32万名39~74岁人群的睡眠习惯与心血 管健康状况,将参与者分为3类: ✅ "早睡早起型":白天更活跃,就寝更早(如晚上9点),约占24%。 ✅ "中间时间型":自述入睡时间介于两者之间。 ✅ "晚睡晚起型":深夜就寝(如凌晨2点),习惯一天晚些时候活动。 结果发现,睡够时长也救不了心脏,"晚睡晚起型"心血管疾病发病风险与"中间时间型"相比增加了 16%;"早睡早起型""中间时间型"参与者总体心血管健康状况较好。 研究截图 研究人员表示,"晚睡晚起型"的人生物钟与自然昼夜不匹配,且更有可能伴随饮食质量差、吸烟等影响 心血管健康的行为。 不过,还有机会挽回吗?对"晚睡晚起型"的人来说,改善 ...
ResMed(RMD) - 2026 Q2 - Earnings Call Transcript
2026-01-29 22:30
Financial Data and Key Metrics Changes - The company reported an 11% headline revenue growth and a 9% growth on a constant currency basis for the second quarter of fiscal year 2026, with GAAP EPS growth of 16% [4][28] - Gross margin increased by 110 basis points year-over-year and by 30 basis points sequentially, reaching 62%-63% for fiscal year 2026 [30][31] - Operating profits increased by 19%, with an operating margin improvement to 36.3% compared to 34% in the prior year [32] Business Line Data and Key Metrics Changes - Global devices revenue experienced high single-digit growth, while masks, accessories, and other revenue saw double-digit growth [4][5] - Residential care software revenue increased by 5% on a constant currency basis, driven by strong performance from the Medifox Dan software vertical [30] Market Data and Key Metrics Changes - Sales in the U.S., Canada, and Latin America increased by 11%, with a 6% increase on a constant currency basis [29] - In Europe, Asia, and other regions, device sales increased by 5% on a constant currency basis, while masks and other sales increased by 8% [29] Company Strategy and Development Direction - The company aims to build a leading digital health ecosystem encompassing sleep health, breathing health, and healthcare technology delivered in the home [8] - Continued focus on operational excellence and innovation, with a commitment to R&D investments of 6%-7% of revenues and SG&A investments of 19%-20% [26][31] - The company is expanding its digital sleep health concierge capabilities and enhancing its manufacturing footprint to improve delivery efficiency [10][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in re-accelerating growth in Europe, Asia, and the rest of the world, with expectations of sustainable high single-digit growth in the residential care software business by fiscal year 2027 [5][6] - The company is closely monitoring the global trade environment and regulatory landscape, with positive implications from recent developments in competitive bidding programs [21][23] Other Important Information - The company returned $263 million to shareholders through dividends and $175 million in share repurchases during the quarter, with plans to increase share repurchases to over $600 million for fiscal year 2026 [34][26] - The launch of new AI-enabled products, such as Comfort Match, is expected to enhance patient adherence to therapy [12][19] Q&A Session Summary Question: Strong US mask number and impact of Virtuox - Management confirmed that the strong growth in masks includes contributions from Virtuox, but even without it, there was solid double-digit growth in masks and accessories [36][38] Question: Update on GLP-1 landscape and its impact - Management noted a 10%-11% higher start rate for CPAP therapy among patients with GLP-1 prescriptions, indicating a motivated patient group [39][41] Question: SG&A growth ahead of revenue growth - Management explained that the SG&A growth includes impacts from the Virtuox acquisition and promotional activities, but underlying growth is tracking closely with revenue [43] Question: Impact on patient funnel stages - Management highlighted significant progress in the top of the funnel due to increased awareness from Big Pharma and tech, while focusing on scaling home sleep apnea testing [45][47] Question: Potential return of Philips to the US market - Management expressed confidence in competing effectively against Philips, noting that they have been performing well in various markets despite Philips' presence [60][62]
ResMed (NYSE:RMD) FY Conference Transcript
2026-01-12 19:32
Summary of ResMed's Conference Call Company Overview - **Company**: ResMed - **Market Cap**: Approximately $37 billion [2] - **Revenue**: $5.3 billion in the trailing 12 months with gross margins around 59-62% and net operating profit margins above 30% [3][30] - **Business Segments**: - Sleep health and breathing health solutions - Software business contributing 12% of revenue [3][4] - **Geographic Distribution**: 58% of revenue from the US, Canada, and Latin America; strong presence in Europe and Asia [3] Investment Opportunity - **Target Markets**: Large addressable markets including sleep apnea, insomnia, and chronic obstructive pulmonary disease [4][5] - **Megatrends**: - Integration of sleep apnea detection in wearables by Big Tech (e.g., Apple, Samsung) [5][44] - Increased patient flow into healthcare due to new GLP-1 drugs [6][22] - **Innovation and Operating Excellence**: Strong cash flow generation of $1.8 billion in the last 12 months, with a focus on R&D, share buybacks, and acquisitions [6][30] Product Innovations - **New Products**: - AirTouch N30i and AirTouch F30i masks with fabric technology for improved comfort [12][53] - AI-enabled medical devices to enhance patient adherence to therapy [13][15] - **Digital Health Initiatives**: Launch of a digital sleep health concierge named Dawn to assist patients in managing their sleep health [16] Market Dynamics - **Competitive Landscape**: - ResMed maintains a strong lead over competitors in the US and globally, with a focus on innovation and patient adherence [35][36] - A major competitor has returned to the market, but ResMed has continued to grow its market share [37] - **Regulatory Environment**: - CPAP therapy excluded from the latest round of competitive bidding, which is seen as a positive for the industry [38][39] Patient Engagement and Education - **Primary Care Physician Education**: - 60,000 CME courses on sleep apnea have been downloaded, with 77% of physicians indicating they will change their practice protocols [26] - **Patient Adherence**: - Patients on GLP-1 medications show higher adherence rates to CPAP therapy, with a 10.8% higher probability of starting CPAP treatment [23][50] Financial Performance - **Capital Distribution**: Over $3.7 billion distributed in the last three years, with a focus on R&D and shareholder returns [30][31] - **Share Repurchases**: Plans for at least $600 million in share repurchases in fiscal year 2026 [31] Future Outlook - **Growth Projections**: Anticipated high single-digit growth with continued leverage on the P&L [33] - **Manufacturing Expansion**: New facilities in the US to support increased manufacturing capacity, aligning with the "Made in America" initiative [29] Conclusion - ResMed is positioned as a compelling investment opportunity due to its strong market presence, innovative product offerings, and strategic focus on patient engagement and education [34]
2025年度10大营养热词发布
Xin Lang Cai Jing· 2026-01-12 19:03
Core Insights - The article discusses the release of the top ten nutrition buzzwords for 2025, reflecting public interest and trends in nutrition and health [2] Group 1: Pre-prepared Meals - "Pre-prepared meals" are defined as factory-processed, pre-packaged dishes, and should be evaluated based on safety and nutritional value rather than labeled as simply "good" or "bad" [3] - Consumer concerns about pre-prepared meals include poor ingredient quality, use of additives, unsatisfactory taste, and low nutritional value, most of which can be addressed through scientific processes and strict management [3] - Consumers are advised to pay attention to ingredient lists and nutritional labels, particularly sodium and fat content, and to complement pre-prepared meals with fresh fruits and quality staples for balanced nutrition [4] Group 2: Anti-inflammatory Diet - Chronic inflammation is linked to various diseases, and public interest has shifted from "beauty and anti-inflammation" to "disease prevention and anti-inflammation" [5] - An anti-inflammatory diet emphasizes the consumption of fresh plant-based foods, healthy fats, and high-antioxidant ingredients while reducing processed foods and certain meats [6] Group 3: Anti-aging - Anti-aging focuses on delaying the aging process and improving quality of life, with a shift towards proactive health management across all age groups [7] - Research indicates that a high-quality diet is associated with reduced risks of functional decline and improved metabolic and cognitive health [7] Group 4: Smart Canteens - Smart canteens utilize information technology to enhance food safety, nutrition management, and operational efficiency, catering to various settings like schools and communities [8] Group 5: Gut Health - Gut microbiota plays a crucial role in health, influencing immune function and chronic inflammation, which can be disrupted by poor diet and lifestyle [9] - A diet rich in dietary fiber and low in processed foods is essential for maintaining a healthy gut microbiome [10] Group 6: Sleep Health - Sleep quality is critical for overall health, with a significant portion of the population experiencing sleep disorders, which can lead to increased inflammation and health risks [11] - Certain foods can aid sleep, while lifestyle changes are necessary for improving sleep quality [11] Group 7: Microplastics - Microplastics are prevalent in the environment and food supply, but their health impacts remain unclear due to a lack of reliable detection methods [12] Group 8: Healthy Aging - Healthy aging emphasizes the importance of nutrition throughout the life cycle to extend healthy life expectancy and reduce disease burden [13] Group 9: Weight Management - Public interest in weight management is increasing, with a focus on maintaining a healthy weight through balanced diets and regular physical activity [14] Group 10: Immunity - The understanding of immunity is evolving, with a focus on maintaining immune homeostasis through balanced nutrition and lifestyle choices [15]
王腾回应简历投递回复时间:尽量下周都回复
Xin Lang Cai Jing· 2026-01-11 14:10
Core Viewpoint - The former general manager of Xiaomi's China market and Redmi brand manager, Wang Teng, has announced the establishment of a new company named "Today Sleep," focusing on the development of sleep health-related products and has initiated multi-position recruitment [1] Group 1 - Wang Teng inquired on Weibo about the sleep monitoring products currently used by consumers [1] - A user asked about the response time for job applications, to which Wang Teng replied that due to a small team, he would try to respond to everyone within the next week [1]
王腾新公司已开始公开招聘:有岗位年薪最高可达75万元,暂不招应届生
新华网财经· 2026-01-11 01:51
Group 1 - The core idea of the article is the establishment of a new company named "Today Yixiu" by Wang Teng, former marketing director of Xiaomi, focusing on sleep health products [2][3] - The initial team consists mainly of members from leading tech companies like Xiaomi and Huawei, indicating a strong background in technology [3] - The company is currently recruiting for four positions, requiring a minimum of three years of work experience, with salaries starting at 20,000 yuan per month and the potential for an annual salary of up to 750,000 yuan for the iOS mobile development engineer position [7] Group 2 - The headquarters of the new company is located in Beijing, with plans to consider branches in Shenzhen and Hangzhou in the future [5] - Wang Teng emphasizes the importance of hiring experienced professionals in the early stages of the startup, stating that fresh graduates will be welcomed once the business develops [5] - The company's mission is to help workers improve their energy levels and combat overwork, promoting a culture of taking breaks when needed [5]
2025 年睡眠医学中心品牌推荐:国产智能设备+进口精准诊断如何重塑睡眠健康生态?
Tou Bao Yan Jiu Yuan· 2026-01-09 13:36
Investment Rating - The report does not explicitly state an investment rating for the sleep medicine center industry Core Insights - The sleep medicine center industry is experiencing significant growth, with a compound annual growth rate (CAGR) of 16.17% from 2019 to 2023, and projected to continue growing at a CAGR of 16.34% from 2024 to 2028 [5][9] - The increasing prevalence of sleep disorders among the population is driving demand for sleep medicine services, with a notable decline in sleep quality observed in recent years [10] - The integration of advanced technologies such as artificial intelligence and wearable devices is expected to enhance diagnostic and treatment capabilities in the industry [11][33] Market Background - Sleep medicine centers are crucial for diagnosing sleep disorders and conducting research, yet their construction is insufficient and lacks standardized design [5] - The market is evolving with a growing awareness of sleep health and the entry of various enterprises, leading to diversification in the industry [5][6][7] Market Status - The market size for sleep medicine centers grew from 200.235 billion RMB in 2019 to 364.651 billion RMB in 2023, with expectations to reach 781.497 billion RMB by 2028 [9] - The average sleep duration among the population is around 7 hours, with significant sleep disturbances reported across different age groups [10][14] Market Competition - The competitive landscape includes a tiered structure with leading institutions such as Sichuan University West China Hospital and Peking University Institute of Mental Health at the forefront [19][21] - The industry is characterized by a fragmented development model, primarily driven by traditional medical disciplines, leading to a shortage of specialized talent and resources [19][20] Development Trends - The industry is moving towards smart and precise healthcare solutions, with AI applications enhancing sleep data analysis and treatment personalization [33] - A multi-disciplinary collaboration model is emerging, integrating various medical specialties to address the complexities of sleep disorders [34] - Policy initiatives are promoting the establishment of sleep clinics and integrating sleep medicine into public health systems, which is expected to drive market growth [36] - Service models are evolving from hospital-based care to comprehensive management that includes home and community services, enhancing accessibility and patient engagement [37]